跳至主要内容
临床试验/NCT02419027
NCT02419027Unknown不适用

A Multi-center Human Study to Evaluate the Efficacy and Safety of ®GI Flora in Subjects With Irritable Bowel Syndrome

Seoul National University Hospital0 个研究点目标入组 116 人开始时间: 2015年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
116
主要终点
Visual Analogue Scale for abdominal pain

研究概览

简要总结

A Multi-center, Randomized, Double-blinded, Placebo-controlled Human Study to Evaluate the Efficacy and Safety of probiotic mixture(®GI Flora) in Subjects with Irritable Bowel Syndrome.

Regimen: 6 probiotics mixture >10^9/D for 8 weeks

Primary variable: visual analogue scale(VAS) assessment for abdominal pain

Secondary variable:

  1. change of VAS score for abdominal pain/discomfort after 4/8-week treatment
  2. daily symptom score for bloating, defecation discomfort(strain/urgency/incomplete evacuation), flatulence , feces shape, frequency of bowel movements

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Irritable bowel syndrome patients according to Rome III criteria
  • •Recurrent abdominal pain or discomfort for at least 3 days per month in the last 3 months associated with at least 2 of the following characteristics: a) improvement with defecation; b) onset associated with a change in the frequency of stool; c) onset associated with a change in form (appearance) of stool.

排除标准

  • •Intolerable or hypersensitive to GI Flora.
  • •Patients with active colon diverticulitis.
  • •History of GI surgeries except hernia repair, appendectomy, primary closure due to perforation.
  • •History of inflammatory bowel disease, malignancy requiring surgery or chemotherapy or radiation within 5 years.
  • •Patient has any condition that, in the opinion of the Investigator, would compromise the well-being of the patient or the requirements of the study.

研究组 & 干预措施

GI Flora

Experimental

Lactobacillus acidophilus LA1 1.312% Lactobacillus rhamnosus LR5 0.656% Lactobacillus paracasei LPC5 0.656% Bifidobacterium lactis BL3 1.312% Bifidobacterium breve BR3 1.312% Pediococcus pentosaceus SL4 1.312% Prolac-T(heat-killed L. acidophilus LA1) 24.286% Dextrose 60.000% Maltodextrin 7.154% Lemon flavor 1.000% Mg-stearate 1.000% TOTAL 100% (1.4g)%

干预措施: GI Flora (Dietary Supplement)

placebo

Placebo Comparator

Dextrose 89.846% Maltodextrin 7.154% Lemon flavor 1.000% Mg-stearate 1.000% TOTAL 100% (1.4g)%

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Visual Analogue Scale for abdominal pain

时间窗: 8 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验